Home > Healthcare > Medical Devices > U.S. Vitrification Market

U.S. Vitrification Market Trends

Report ID: GMI10251
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

U.S. Vitrification Market Trends

The increasing demand for fertility treatments has driven more people to opt for ART. As more individuals and couples seek options such as IVF and egg freezing, the need for advanced preservation methods has surged in demand. Vitrification, a rapid freezing technique, is crucial in enhancing the success rates of ART procedures, thereby fuelling market growth. This trend reflects the broader acceptance and reliance on fertility treatments in the U.S.

For instance, in April 2024, the Society for Assisted Reproductive Technology reported a 2.5% increase in U.S births from IVF, with 91,771 babies born in 2022 compared to 89,208 in 2021. The total number of IVF cycles performed at Society for Assisted Reproductive Technology (SART) member clinics grew by over 6% to 389,993 in 2022, reflecting rising demand for IVF services despite legal challenges. Similarly, egg-freezing cycles also increased to 29,803, up from 24,560 in 2021, indicating a growing interest in ART options. Thus, this growth in ART procedures has driven the expansion of the market, which is crucial for preserving gametes and embryos used in these treatments.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. vitrification market size was USD 3.4 billion in 2023 and is expected to register 9.8% CAGR from 2024-2032 owing to the increasing infertility rates that surged the demand for advanced fertility treatments in the country.

The devices segment reached USD 1.5 billion in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to its pivotal role in rapidly freezing biological specimens for preservation.

Northeast zone vitrification industry is expected to register 9.2% CAGR from 2024-2032 due to a significant presence of advanced medical facilities and research centers focused on reproductive health in the states.

FERTIPRO NV, FUJIFILM Irvine Scientific, Genea BIOMEDX, IMV Technologies Group (Cryo Bio System), Kitazato Corporation., MFC Global, MINITÜB GMBH, NidaCon International AB, Optimas, Shenzhen VitaVitro Biotech, and Vitrolife, are some of the major vitrification companies in the U.S.